Literature DB >> 6800393

Free sodium valproate monitoring.

E J Roman, P Ponniah, J B Lambert, N Buchanan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6800393      PMCID: PMC1402109          DOI: 10.1111/j.1365-2125.1982.tb01403.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  7 in total

1.  Value of measuring salivary and free serum sodium valproate concentrations.

Authors:  N Buchanan; P Ponniah
Journal:  Med J Aust       Date:  1981-05-16       Impact factor: 7.738

Review 2.  Monitoring of free valproic acid levels?

Authors:  R H Levy
Journal:  Ther Drug Monit       Date:  1980       Impact factor: 3.681

3.  The estimation of plasma valproate by gas-liquid chromatography.

Authors:  M H Wood; D C Sampson; W J Hensley
Journal:  Clin Chim Acta       Date:  1977-06-15       Impact factor: 3.786

4.  Pharmacokinetics of di-n-propylacetate in epileptic patients.

Authors:  F Schobben; E van der Kleijn; F J Gabreëls
Journal:  Eur J Clin Pharmacol       Date:  1975-02-28       Impact factor: 2.953

5.  Valproic acid binding to human serum albumin and determination of free fraction in the presence of anticonvulsants and free fatty acids.

Authors:  I H Patel; R H Levy
Journal:  Epilepsia       Date:  1979-02       Impact factor: 5.864

6.  Decreased plasma protein binding of phenytoin in patients on valproic acid.

Authors:  R Dahlqvist; O Borgå; A Rane; Z Walsh; F Sjöqvist
Journal:  Br J Clin Pharmacol       Date:  1979-12       Impact factor: 4.335

7.  Valproic acid dosage and plasma protein binding and clearance.

Authors:  A T Bowdle; I H Patel; R H Levy; A J Wilensky
Journal:  Clin Pharmacol Ther       Date:  1980-10       Impact factor: 6.875

  7 in total
  1 in total

1.  Clinical Pharmacokinetic Monitoring of Free Valproic Acid Levels: A Systematic Review.

Authors:  Kevin Lin; Vivien F S Cao; Charles Au; Karen Dahri
Journal:  Clin Pharmacokinet       Date:  2022-08-30       Impact factor: 5.577

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.